Parkinson’s Disease Recovery
Resetting the Human Brain
Reversing the Effects of Parkinson’s Disease, Exercising Neuroplasticity and Removing Brain Function Limitations.
This device and treatment can be be used on all forms of cognitive disease and disfunction for patients suffering from; Parkinson’s Disease, Alzheimer's, dementia, cognition/movement disorders as well as; healthy brains exercising neuroplasticity, enhancing brain function, clarifying thought and speed of processing, reducing psychological and emotional disturbances and eliminating other forms of cognitive impairment.
The Treatment and Technology
The treatment begins with a patient electroencephalograph (EEG). These brainwave readings are then normalized to simulate non PD brainwaves. These normalized brainwaves are feed into AI enabled micro processors. The processors control a direct drive mechanical device.
The patient is locked onto the device. The new normalized signals are fed into the nervous and muscular system. The brain begins to adjust to these new brainwave signals. As the brain normalizes the Parkinson’s Disease cognitive and physical loses fade as the brain resets to pre Parkinson’s Disease cognitive and physical functionality.
The progression of the recovery from Parkinson’s Disease (PD) has distinct phases. Each stage becomes the foundation for the next phase. The first phase includes adjustment to the technology and a shift away from the prevailing belief that there “is no effective treatment and no cure for PD”. The return of cognitive losses happens in the first few weeks. As cognition shifts the belief in the possibility of an effective treatment returns hope. As hope is reestablished returns from losses happen quickly. This lays the foundation for the next phase.
The DNA Snap
The next phase is the DNA snap. Research suggests that memories are stored in DNA. My experimental observations suggest that its not the actual memories that are stored, but the visceral experience surrounding a highly impactful event that is stored in DNA. An example might be a car crash. The victim may recall backing out of the driveway and waking up in the hospital, yet nothing in between. Memories may return quickly or may not return for several years, if at all. These memories are reconstructions. What is not a reconstruction is the sensory information. Sight, sound, smell etc. are experienced and stored. It is this information or data that is stored in DNA. As the technology resets the brain it is this stored data that returns. This DNA snap happens in the few weeks following the initial phase and it returns with a wallop. The brain initially resets and returns to a moment of significant trauma. I suspect that this trauma is the initiating event that turns on the genetic predisposition for Parkinson’s Disease. I theorize that the trauma undermines the immune systems ability to keep the PD genes in check and once released the fast or slow march to full fledged PD begins. Once this traumatic event is viscerally released what has been lost to PD fades as the return to a pre-PD condition begins to accelerate.
The third phase sees an increase in the intensity of the treatment. As the patient begins to accommodate this increased intensity the returns continue to accumulate. This is especially true in the case of cognitive returns. The physical returns tend to oscillate in and out as the patient tries to accommodate these new patterns. This phase can take a few months and the patient is at risk of partial relapse into some of the old PD symptoms. The cognitive improvements remain steady, while the physical improvements (which are remarkable) are in a constant battle with the side effects of previous medical interventions especially if the medical interventions are still ongoing.
This final phase is a time of decision for the patient. There is a psychological effect where the patient forgets what their pretreatment state was like (hence the use of video) and they begin to take control of their treatment in the belief that they will take it from here. This leads to a reduction in the physical improvements although the cognitive returns are firmly established and in fact begin to surpass previous cognitive abilities.
The side effect of the DNA Snap
Trauma, Neuroplasticity and Transformation
The side effect of releasing trauma is having to revisit, remember and re-experience the trauma. The DNA Snap emerged during the first application of the technology and has been present in every user to date. While unforeseen it has been the cornerstone of the removal of impairment and the reestablishment of cognitive and physical health and transformation. The PD treatment does not require any psychodynamic exploration. It is only necessary that the patient notices the visceral effect (the felt bodily sense) that comes up during the first phase of the treatment. If the patient struggles with this effect it must be addressed, but it is not a necessity for the PD treatment to be effective. Once the effect is noted the recovery accelerates.
This is where the topic of Parkinson’e Disease recovery, neuroplasticity and human transformation split into three different threads. All three flow from the application of the technology, yet each is compelling only to the users desired outcome; PD patients want relief and recovery from their disease; Those experiencing cognitive impairment or those anticipating future impairment (from hereditary neurological disorders) want a way to exercise neuroplasticity in the hope of recovery from impairment or fending it off for as long as possible, if not forever; Transformation was an unforeseen possibility that emerged very late in the use of the technology on a “normal” brain well beyond the required number of treatments for PD patients.
The Parkinson’s Disease Treatment blog continues below, while the other two topics begin in the Exercising Neuroplasticity blog and the Post Human Emergent Transformation blog.
Parkinson’s Disease Treatment blog (continued):
The PD patient commits to a minimum of four months treatment. Presently the treatment is administered and monitored one-on-one. The treatment can take place in a clinic or in the patient’s home. Treatment is one hour a day, five days a week. Once the initial treatment cycle is complete the patient then self administers, either when symptoms begin to reemerge or one to three days a week in a post treatment maintenance program.
A clinic environment is also possible, but it requires a minimum of 10 patients.
There is also the possibility and necessity of the entire process taking place remotely. This availability is in its infancy. A few potential patients have requested this and the technology is ready for beta testing.
This treatment has been a decade in the making, testing and application. It has been solely funded by the inventor/researcher. This will have to change. One-on-one is expensive. The establishing of a clinic is also expensive. Presently this funding will have to come from the patient or a benefactor acting on the patients behalf.
Developmental History of the Treatment and Self Funding.
The PD treatment grew from a post doctoral exploration into dementia. During this exploration a friend of the researcher was diagnosed with PD. Research across the PD treatment literature suggested small, short lived micro-improvements in a myriad of very different approaches to PD treatment. Recognizing these connections and the possibility of capturing these micro-improvements and expanding the efficacy and duration, PD then became the primary focus.
Recognizing that funding opportunities were very limited for a single researcher who was not working at a university or a pharmaceutical firm pursuing PD research the decision was made to continue unfunded. The far reaching consequences of this decision led to a research freedom that would not be available at an institution. It also led to an erosion of personal finances and relationships. Once the PD Pandora’s Box was pried open the lid was never going to fit back on.
From the moment the first patient was diagnosed to the development of an effective treatment for PD was 7 years. The technology went through a number of iterations as the application efficacy was narrowed to an effective treatment that resulted in the recovery of a significant number of losses due to PD. Covid added another 2 years. This time was spent on further refinements. The following video is from the first PD patients’ treatment.
Following this first effective treatment an application was made to the Michael J Fox Foundation (MJFF) for research and clinical funding. After some back and forth emails during the funding application process it was made clear that video evidence would not be allowed. The application was rejected. During the next funding cycle the possibility of a lone researcher applying for funding had been removed from the MJFF application portal. After billions of dollars in contributions and hundreds of million in research its likely that Michael J Fox will succumb to the ravages of PD. It is disheartening to watch.
It has been my experience that the PD funding agencies, which have great intentions, have limited their research support for fairly mainstream research protocols. To date there is still a medical and treatment industry standard statement; After the initial PD diagnosis the next sentence is “there is no treatment and no cure”. This has been frustrating. This is the primary reason for the necessity for PD patients and their benefactors to self fund this treatment presently.
This remarkable technology continues to be developed as its efficacy continues to be tested. The initial versions (Generation 1 and 2) worked without AI enabled microprocessors. Presently Generation 5 is in use with Generation 6 coming as a possibility for remote treatment. Remote treatment is the cornerstone for scaling the technology to get it to the PD population as a whole.
A Narrative
Knocking on PD’s doors.
Establishing legitimacy for the technology, research and application has gone hand in hand with pounding on the foundations of the disease to render up its secrets while also pounding on the major funding and treatment institutions for some help, or at least some interest.
The closest I got to the Michael J. Fox Foundation was a run through the front doors. After the initial application rejection and the subsequent removal of any possibility of a sole researcher being able to apply I phoned the foundation. A newly hired employee answered the phone. After hearing my pitch I was passed over to a VP where I left a long message about the technology and its efficacy. I never heard from the MJFF again. It felt necessary to get as far as I could with them and this felt like a hard stop, although I did pursue their sister agency, The Edmond J. Safra Fellowship in Movement Disorders. Their response was they do not allow unsolicited applications for funding.
Google founder and philanthropist Sergey Brin’s involvement with PD led to the next swing and a near miss. Sergey’s mother had PD and Sergey has the mutation in the LRRK2 gene. He has contributed more than a billion dollars to PD research. I attempted to make contact with his foundation, but that was met with a resounding silence. No response.
I also traveled to Houston to visit the Parkinson’s Disease Center and Movement Disorders Clinic at the Baylor College of Medicine. The head of the department was away, but the Fellowship Coordinator took the time to listen to my story, committed to reviewing the video evidence and ensured me that her boss would watch the video of my initial PD patient. He did and he responded; “More data please”.
Kite (surfing) lines get entangled
The Maui Sessions
I have been a kite surfer for over twenty years and remarkably PD and kitesurfing are entangled. There were mutiple reasons for visiting Baylor; The reputation of the PD clinic; and the head of the department, who is also a member of The Michael J. Fox Foundation’s Scientific Advisory Board, also has a long-term patient that is a kitesurfer. In response to more data I thought it would be best to treat this patient as a demonstration of the efficacy of the technology. Sergey Brin is also a kite surfer.
One of the finest (and fearless) ambassadors for kite surfing is Jessie Richman. His father, also a windsurfer and kitesurfer, has PD and is a Baylor PD clinic patient. In a 2021 wonderful post-Covid conversation in Hood River, Oregon (summer time kite surfer heaven) I committed to Jessie to travel to Maui if I could and treat his father Joel.
In the spring of 2024 I began working with Joel on Maui. During the course of his treatment the VC investor Bill Tai and his annual Maui kite surfing, young tech get-together met on Maui. Jessie managed to get me a post kitesurfing session audience with Bill and his young tech cohorts. I spent an hour discussing my research, answering their questions and drinking their generously offered beer (remember, I am on an ever diminishing shoe string budget and a few free beer are a welcome recompense). They were polite, inquisitive and I appreciated their sincere curiosity. I left feeling I made little impact, but the next day Jessie said no. They were very interested to which I responded “More data…correct” Yes he said.
A few of this cohort approached me the next day with more questions and comments. The most prevalent was the need for me to get an apprentice. The accumulated knowledge I have must be passed on and this would also free me to go on with the neuroplasticity technology that had emerged from the research and to ensure that what had been accomplished would not be lost. I was beginning to feel my age in this, but their comments were well received. I left wondering if what I need is a human apprentice or an AI generated assistant, an AI synthesis of a sentient form of myself in some way.
I continued with Joel through to the end of the PD treatment cycle.
A tack back around to Sergey Brin happened again while on Maui. The Lahaina fire devastated and impacted almost everyone living on Maui. It is deeply felt in the loss that everyone here shares. The Maui Economic Development Board has been valiantly trying to rebuild an economy hit doubly hard with the Lahaina fire and Covid in a way that is not tourist dollar driven. I took their startup bootcamp and during the course I chatted with a presenter that is a shining example of a Maui tech company that is bringing new industry to the Island. He is the founder of a very successful satellite tracking company that is fiercely Maui rooted. When presenting he talked about his initial startup history including with Apple co-founder Steve Wozniak. He was also friends with Steve’s second wife Candy “Kayak” Clark. It turns out that both Candy and I raced at the same 1977 World Whitewater Kayaking Championships in Spittal, Austria and the two highlights for me were the racing and dancing the night away with Candy at the post race party. She is a terrific dancer. The founder of the Maui Satellite Tracking company had contact information for Sergey and agreed to try to pass on my contact information. The response from the Brin side was “there is no interest in making an introduction at this time”. A swing and a miss, although I still have hope that the Sergey Brin Foundation may cast a future curious glance in my direction, possibly after a shared Big Wave Kite Surfing day on Maui’s north shore.
There have been a lot of strikeouts on this journey. There have also been a lot of kind and generous tender mercies that I am so thankful for. All the people I have mentioned that have tried to move this PD treatment along by listening and acting have contributed to keeping a diminishing hope alive. For this I will be forever thankful. These great human qualities are alive and well in these humane gestures. Mahalo and Thank You.
One last note on the above. The lawyer that negotiated the $4 billion+ Lahaina victims compensation package has PD. The PD world is small yet far reaching.
In the meantime any gesture of support, both personal and financial, regardless of size will go a long way to help in the continuation of this journey. If there is interest I will continue to persevere until the support and resources evaporate or the PD world begins to take notice. Regardless, the inner voice says “continue to treat PD, one at a time if you have to” and I will try even in the face of the other technologies that have emerged from this journey that are now begging for attention.
